We publish only what we can stand behind. This page documents our security posture, every claim we make publicly, and — just as importantly — what we deliberately do not claim.
Corterve is a product of MannaSync Solutions Inc. It helps patients find clinical trials that may be relevant, and helps research sites and sponsors reach those patients. It does not determine eligibility and does not promise an enrollment outcome.
Connections to Corterve's website and app are encrypted using TLS (version 1.2 or higher).
Each claim below is active, reviewed on the date shown, and supported by the evidence type listed.
“Connections to Corterve's website and app are encrypted using TLS (version 1.2 or higher).”
Scope
All user connections to Corterve website and web application.
Evidence
HTTPS enforcement and TLS termination configuration (version 1.2 or higher).
Appears on
/trust, homepage, /about
Review date
2027-10-09
“Lean sites come to Corterve for study finding, participant finding, or both. Community engagement remains available for sponsors and CROs. Design support is an optional add-on.”
Scope
All public-facing commercial pages.
Evidence
Public site IA: /for-sites and its acquisition pages are the site offers; /sponsors is the sponsor/CRO landing; /services is the sponsor catalog; /for-organizations and /community are thin routers. /community/sponsor and /community/site redirect into those funnels.
Appears on
/, /for-sites, /for-sites/study-acquisition, /for-sites/patient-acquisition, /for-organizations, /contact, /services, /sponsors
Review date
2026-11-10
Transparency means being clear about what we don't say, not just what we do. The following are topics where we deliberately do not make public claims.
We do not display invented certifications, compliance badges, or seals — including regulatory compliance badges and third-party seals. We describe what our code does, not what an auditor has certified.
We do not claim that Community Connect or any Corterve service accelerates enrollment by any specific percentage. Outreach is a strategy with no promised outcome.
We do not award studies or select sites. We take on study finding; sponsors and CROs still decide the award.
We do not claim that our outreach alters control group responses, improves treatment signal, or produces a measurable enrollment outcome.
We do not sell or describe proprietary architecture, match scores, activation engines, or other internal machinery on public pages. Public copy describes the finding work we take on.
We do not publish invented enrollment percentages, sample report numbers, ROI models, or case-study quotes that imply a promised outcome.
The published site license is $99/month. Custom sponsor/CRO programmes are scoped with us. We do not publish unpublished SKUs or volume discounts.
We do not describe our platform as "AI-powered." We connect patients to relevant trials based on their health profile and location.
We do not claim to pre-screen patients. We surface trials that may be relevant; the research team determines eligibility.
We do not claim 24/7 support availability. Our contact routes are monitored during business hours.
We do not make public claims about de-identification methods or absolute privacy assurances.
We do not publicly claim penetration test results or security audit outcomes.
We do not publish a public API catalog, sample demand scores, feasibility scores, enrollment-time estimates, or unpublished partner SLAs. Integrations are scoped with us.
We do not claim affiliation with Harvard Medical School, NIH, FDA, or other institutions. Editorial sources are cited per article, not as an implied endorsement.
Public marketing, legal, discovery, contact, and partner-integration pages on corterve.com. Finding work only — no award, eligibility determination, enrollment, trial-outcome, unpublished-price, public-API-score, or BAA-as-product claims. Signed 2026-09-18.
